StonvexLoading…
StonvexStonvexStonvexCore line items from SGMO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $39.55M | $57.80M | $176.23M | $111.30M |
Operating Income | $-121.24M | $-103.97M | $-274.00M | $-201.28M |
Net Income | $-122.93M | $-97.94M | $-257.83M | $-192.28M |
EPS (Diluted) | $-0.44 | $-0.49 | $-1.48 | $-1.25 |
Total Assets | $59.74M | $101.64M | $165.32M | $562.51M |
Total Liabilities | $74.01M | $78.86M | $82.43M | $267.55M |
Cash & Equivalents | $20.95M | $41.92M | $45.20M | $100.44M |
Free Cash Flow OCF − CapEx | $-97.31M | $-67.41M | $-246.00M | $-243.80M |
Shares Outstanding | 350.69M | 212.84M | 178.13M | 166.79M |